Rio Tinto Limited

Posted on | by Algo Engine | Leave a Comment on Rio Tinto Limited

Rio Tinto a new position in Rio Tinto Limited at an entry price of $153.23, with a protective stop-loss price established at $142.20. The company continues to maintain its status as a global mining powerhouse, recently reporting robust production volumes across its core iron ore and copper divisions.

  • Rio Tinto is a primary supplier of high-grade iron ore from the Pilbara region, benefiting from low-cost operations and strong industrial demand in Asia.
  • The company is aggressively expanding its footprint in future-facing commodities, including significant investments in copper and lithium projects to support the global energy transition.
  • Rio Tinto remains a key dividend-payer in the ASX 200, supported by a disciplined balance sheet and high operational margins.

[/cb_decision]

4D Medical

Posted on | by Leon Hinde | Leave a Comment on 4D Medical

4Dmedical

Price Movement: Shares surged as much as 38% in early trade, reaching a record high of $6.40.

The primary catalyst for today’s rally is the announcement that 4DMedical’s flagship CT:VQ™ technology has been deployed at the Mayo Clinic in the United States.

  • Significance: Mayo Clinic is globally recognized as one of the world’s leading healthcare institutions. This partnership is viewed by the market as a “landmark moment” and a top-tier endorsement of 4DMedical’s respiratory imaging technology.
  • Agreement Details: The clinic will integrate CT:VQ into clinical workflows for ventilation and perfusion analysis, allowing clinicians to evaluate the technology across multiple use cases.

### Market Reaction

Commercial Momentum: This marks the company’s sixth major U.S. deployment in just seven months since receiving FDA clearance in September 2025. Other major sites include the Cleveland Clinic, Stanford, UC San Diego Health, University of Chicago Medicine, and the University of Miami.